<mets:mets xsi:schemaLocation="http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" OBJID="eprint_87619" LABEL="Eprints Item" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:mets="http://www.loc.gov/METS/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mets:metsHdr CREATEDATE="2026-06-16T23:28:48Z"><mets:agent ROLE="CUSTODIAN" TYPE="ORGANIZATION"><mets:name>Arxiv Universal Publishings</mets:name></mets:agent></mets:metsHdr><mets:dmdSec ID="DMD_eprint_87619_mods"><mets:mdWrap MDTYPE="MODS"><mets:xmlData><mods:titleInfo><mods:title>THE DAWN OF HUMAN REJUVENATION: FROM SCIENCE FICTION TO CLINICAL REALITY : A COMPREHENSIVE REVIEW OF CELLULAR REPROGRAMMING, SENOLYTICS, AND EPIGENETIC INTERVENTIONS</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Dr. Saloni</mods:namePart><mods:namePart type="family">Jain</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Muzzamil Tariq</mods:namePart><mods:namePart type="family">Chowdhary</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Ritshi</mods:namePart><mods:namePart type="family">Amchi</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Numanbhai</mods:namePart><mods:namePart type="family">Mansuri</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Human aging, once considered an immutable biological certainty, is now being actively targeted by scientific interventions that demonstrate measurable age reversal at the cellular and organismal levels. This comprehensive review examines three primary therapeutic modalities leading the rejuvenation revolution: partial cellular reprogramming using Yamanaka factors, senolytic therapies targeting senescent cells, and epigenetic reprogramming through methylation-supportive interventions. Drawing from recent clinical trials, preclinical studies, and market analysis, we present evidence that biological age reversal of 4-11 years has been achieved in human subjects through non-pharmacological interventions, while cellular reprogramming has extended median remaining lifespan by 109% in aged murine models. The longevity biotechnology sector has attracted over $7.5 billion in investment between 2022-2025, signaling unprecedented institutional confidence in aging as a tractable therapeutic target. This article synthesizes current evidence for rejuvenation biology, addresses safety considerations and translational challenges, and projects the trajectory toward human clinical applications.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2026-04-23</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Research Science and Innovation House</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mets:xmlData></mets:mdWrap></mets:dmdSec><mets:amdSec ID="TMD_eprint_87619"><mets:rightsMD ID="rights_eprint_87619_mods"><mets:mdWrap MDTYPE="MODS"><mets:xmlData><mods:useAndReproduction>
<p xmlns="http://www.w3.org/1999/xhtml"><strong>For work being deposited by its own author:</strong>
In self-archiving this collection of files and associated bibliographic
metadata, I grant Arxiv Universal Publishings the right to store
them and to make them permanently available publicly for free on-line.
I declare that this material is my own intellectual property and I
understand that Arxiv Universal Publishings does not assume any
responsibility if there is any breach of copyright in distributing these
files or metadata. (All authors are urged to prominently assert their
copyright on the title page of their work.)</p>

<p xmlns="http://www.w3.org/1999/xhtml"><strong>For work being deposited by someone other than its
author:</strong> I hereby declare that the collection of files and
associated bibliographic metadata that I am archiving at
Arxiv Universal Publishings is in the public domain. If this is
not the case, I accept full responsibility for any breach of copyright
that distributing these files or metadata may entail.</p>

<p xmlns="http://www.w3.org/1999/xhtml">Clicking on the <em>Deposit Item Now</em> button indicates your agreement to these
terms.</p>
    </mods:useAndReproduction></mets:xmlData></mets:mdWrap></mets:rightsMD></mets:amdSec><mets:fileSec><mets:fileGrp USE="reference"><mets:file SIZE="171" MIMETYPE="application/xml" ID="eprint_87619_14213_1" OWNERID="https://arxiv.universalpublishings.com/id/eprint/87619/1/main.bin"><mets:FLocat xlink:href="https://arxiv.universalpublishings.com/id/eprint/87619/1/main.bin" xlink:type="simple" LOCTYPE="URL"></mets:FLocat></mets:file></mets:fileGrp></mets:fileSec><mets:structMap><mets:div ADMID="TMD_eprint_87619" DMDID="DMD_eprint_87619_mods"><mets:fptr FILEID="eprint_87619_document_14213_1"></mets:fptr></mets:div></mets:structMap></mets:mets>